Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology
Matthias Augustin, H Chih-ho Hong, Tiago Torres, Naiem T Issa · 2026
Read Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology by Matthias Augustin, H Chih-ho Hong, Tiago Torres, Naiem T Issa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13558492.txt.
Description
A peer-reviewed research article from Europe PMC (2026). b and tralokinumab maintenance of efficacy across endpoints at week 32 comparing the Q2W treatment arms. Results are provided in raw format and visualized in a forest plot. CI confidence interval, EASI Eczema Area and Severity Index, EASI-75/90 ≥ 75/90% improvement in EASI from baseline, IGA Investigator Global Assessment, MAIC matching-adjusted indirect comparisons, NRS numerical rating score, pt point, Q2W every 2 weeks, RD response difference, RR response rate
The original article has been corrected.
Catalog record
| CREATOR | Matthias Augustin, H Chih-ho Hong, Tiago Torres, Naiem T Issa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |